Interferon-free Therapy for Genotype 1 Hepatitis C in Liver Transplant Recipients: Real World Experience from HCV-TARGET

BACKGROUND: Recurrent infection with the hepatitis C virus (HCV) after liver transplantation is associated with decreased graft and patient survival. Achieving sustained virological response (SVR) with antiviral therapy improves survival. Because interferon-based therapy has limited efficacy and is...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Liver Transpl
Autors principals: Brown, Robert S., O’Leary, Jacqueline G., Reddy, K. Rajender, Kuo, Alexander, Morelli, Giuseppe J., Burton, James R., Stravitz, R. Todd, Durand, Christine, Di Bisceglie, Adrian M., Kwo, Paul, Frenette, Catherine T., Stewart, Thomas G., Nelson, David R., Fried, Michael W., Terrault, Norah A.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5208040/
https://ncbi.nlm.nih.gov/pubmed/26519873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lt.24366
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars